61 related articles for article (PubMed ID: 6690060)
41. Sequential administration of varying doses of dacarbazine and fotemustine in advanced malignant melanoma.
Lee SM; Margison GP; Woodcock AA; Thatcher N
Br J Cancer; 1993 Jun; 67(6):1356-60. PubMed ID: 8512821
[TBL] [Abstract][Full Text] [Related]
42. Dosage and cycle effects of dacarbazine (DTIC) and fotemustine on O6-alkylguanine-DNA alkyltransferase in human peripheral blood mononuclear cells.
Lee SM; Thatcher N; Dougal M; Margison GP
Br J Cancer; 1993 Feb; 67(2):216-21. PubMed ID: 8431354
[TBL] [Abstract][Full Text] [Related]
43. Formation and loss of O6-methyldeoxyguanosine in human leucocyte DNA following sequential DTIC and fotemustine chemotherapy.
Lee SM; Margison GP; Thatcher N; O'Connor PJ; Cooper DP
Br J Cancer; 1994 May; 69(5):853-7. PubMed ID: 8180013
[TBL] [Abstract][Full Text] [Related]
44. Cell cycle perturbation and cell death after exposure of a human lymphoblastoid cell strain to N-methyl-N'-nitro-N-nitrosoguanidine.
Black KA; McFarland RD; Grisham JW; Smith GJ
Am J Pathol; 1989 Jan; 134(1):53-61. PubMed ID: 2913827
[TBL] [Abstract][Full Text] [Related]
45. Cytotoxicity of 5-(3-methyl-1-triazeno)imidazole-4-carboxamide (MTIC) on Mer+, Mer+Rem- and Mer- cell lines: differential potentiation by 3-acetamidobenzamide.
Lunn JM; Harris AL
Br J Cancer; 1988 Jan; 57(1):54-8. PubMed ID: 2831926
[TBL] [Abstract][Full Text] [Related]
46. Host cell reactivation of gamma-irradiated adenovirus 5 in human cell lines of varying radiosensitivity.
Eady JJ; Peacock JH; McMillan TJ
Br J Cancer; 1992 Jul; 66(1):113-8. PubMed ID: 1637659
[TBL] [Abstract][Full Text] [Related]
47. Immunohistological examination of the inter- and intracellular distribution of O6-alkylguanine DNA-alkyltransferase in human liver and melanoma.
Lee SM; Rafferty JA; Elder RH; Fan CY; Bromley M; Harris M; Thatcher N; Potter PM; Altermatt HJ; Perinat-Frey T
Br J Cancer; 1992 Aug; 66(2):355-60. PubMed ID: 1503911
[TBL] [Abstract][Full Text] [Related]
48. In vivo depletion of O6-alkylguanine-DNA-alkyltransferase in lymphocytes and melanoma of patients treated with CB 10-277, a new DTIC analogue.
Lee SM; Thatcher N; Crowther D; Margison GP
Cancer Chemother Pharmacol; 1992; 31(3):240-6. PubMed ID: 1464162
[TBL] [Abstract][Full Text] [Related]
49. Comparison of virus reactivation, DNA base damage, and cell cycle effects in autologous human melanoma cells resistant to methylating agents.
Hayward IP; Parsons PG
Cancer Res; 1984 Jan; 44(1):55-8. PubMed ID: 6690060
[TBL] [Abstract][Full Text] [Related]
50. Relationships among cell survival, O6-alkylguanine-DNA alkyltransferase activity, and reactivation of methylated adenovirus 5 and herpes simplex virus type 1 in human melanoma cell lines.
Maynard K; Parsons PG; Cerny T; Margison GP
Cancer Res; 1989 Sep; 49(17):4813-7. PubMed ID: 2547518
[TBL] [Abstract][Full Text] [Related]
51. Cyclophosphamide resistance developed in a human melanoma cell line.
Boon MH; Parsons PG
Cancer Treat Rep; 1984 Oct; 68(10):1239-46. PubMed ID: 6525597
[TBL] [Abstract][Full Text] [Related]
52. DNA damage induced by a new 2-chloroethyl nitrosourea on malignant melanoma cells.
Godeneche D; Rapp M; Thierry A; Laval F; Madelmont JC; Chollet P; Veyre A
Cancer Res; 1990 Sep; 50(18):5898-903. PubMed ID: 2393861
[TBL] [Abstract][Full Text] [Related]
53. Cross-sensitivity of methylating agents, hydroxyurea, and methotrexate in human tumor cells of the Mer- phenotype.
Maynard K; Parsons PG
Cancer Res; 1986 Oct; 46(10):5009-13. PubMed ID: 3756862
[TBL] [Abstract][Full Text] [Related]
54. Kinetics of O6-methylguanine repair in human normal and ataxia telangiectasia cell lines and correlation of repair capacity with cellular sensitivity to methylating agents.
Shiloh Y; Becker Y
Cancer Res; 1981 Dec; 41(12 Pt 1):5114-20. PubMed ID: 7307010
[TBL] [Abstract][Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
